Preparation and Safety Evaluation of Topical Simvastatin Loaded NLCs for Vitiligo.

Vitiligo is a long-term common autoimmune disease in which growing patches of skin lose their color. There is no FDA-approved treatment for vitiligo. However, recent studies have demonstrated an immunosuppressive effect on vitiligo lesions in mouse models by simvastatin.